BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9540141)

  • 1. [Retrospective study of drug-induced agranulocytosis in hospitalized patients in Geneva and comparison with cases reported to IOCM].
    Krayenbühl JC; Oestreicher MK; Sievering J; Stoller R; Dayer P
    Schweiz Med Wochenschr; 1998 Feb; 128(6):199-202. PubMed ID: 9540141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
    Zapater Hernández P; Horga de la Parte JF; García AG
    An Med Interna; 2002 Jun; 19(6):275-82. PubMed ID: 12152385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute drug-induced agranulocytosis: experience of the Regional Center of Pharmacovigilance of Lyon over 7 years].
    Vial T; Pofilet C; Pham E; Payen C; Evreux JC
    Therapie; 1996; 51(5):508-15. PubMed ID: 9138385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brasil.
    Hamerschlak N; Montezuma MP; Bacal N; Szterling LN; Rosenfeld LG; Guerra CC
    Rev Paul Med; 1993; 111(1):294-8. PubMed ID: 8235248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced agranulocytosis: clinical study of 19 cases].
    Márquez JA; Pardo C; Amutio E; Cortés C; Piñán MA; Alvarez C
    Sangre (Barc); 1998 Oct; 43(5):436-8. PubMed ID: 9868339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based drug-induced agranulocytosis.
    Ibáñez L; Vidal X; Ballarín E; Laporte JR
    Arch Intern Med; 2005 Apr; 165(8):869-74. PubMed ID: 15851637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and probable etiology of toxic agranulocytosis in a definite population in the province of Buenos Aires (1963-1976)].
    Larregina A; Aggio MC; Alvarez RV
    Medicina (B Aires); 1994; 54(1):13-6. PubMed ID: 7990680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors.
    van Staa TP; Boulton F; Cooper C; Hagenbeek A; Inskip H; Leufkens HG
    Am J Hematol; 2003 Apr; 72(4):248-54. PubMed ID: 12666135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-related deaths in a university central hospital.
    Juntti-Patinen L; Neuvonen PJ
    Eur J Clin Pharmacol; 2002 Oct; 58(7):479-82. PubMed ID: 12389071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse internal medicine drug effects at hospital admission].
    Lepori V; Perren A; Marone C
    Schweiz Med Wochenschr; 1999 Jun; 129(24):915-22. PubMed ID: 10413826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive epidemiology of agranulocytosis.
    Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M
    Arch Intern Med; 1992 Jul; 152(7):1475-80. PubMed ID: 1627027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-induced agranulocytosis in rheumatology. A retrospective study of 12 cases].
    Serraj K; Federici L; Maloisel F; Sibilia J; Andrès E
    Ann Biol Clin (Paris); 2007; 65(4):431-6. PubMed ID: 17627927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced agranulocytosis.
    Chaimongkol B; Nanthachit N; Navarawong V; Siriloiratana P
    J Med Assoc Thai; 1989 Dec; 72(12):666-72. PubMed ID: 2628533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse drug effects observed at French admissions departments and emergency services (Prospective study of the National Educational Association for Teaching Therapeutics and proposals for preventive measures].
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X;
    Bull Acad Natl Med; 2003; 187(4):647-66; discussion 666-70. PubMed ID: 14556474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.